Fishawack News Articles

News

Find out first what Fishawack have been up to and how we’re continuing to grow

Fishawack launches new website and introduces new structure for growth

15th November 2018

The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has launched their new website. The revitalized website introduces the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative, as well as providing news, careers, and contact information for the expanding group, complementing Fishawack’s active presence on LinkedIn and Twitter.

Fishawack Medical Communications partners with global and regional pharmaceutical, biotechnology, and medical device clients to develop and deliver services in the fields of medical communications, scientific engagement, publications, market access, strategic consultancy, and thought leader consultancy.

Fishawack Creative ensures maximum impact for a client from an extensive offering of state-of-the-art services, strategic planning, creative development, brand marketing, and tactical execution. Connecting strategy and creative is the key to brand success and the Fishawack Creative team have demonstrated the effectiveness of this approach on some of the largest brands in the global pharmaceutical marketplace.

“It is great to have a fresh website that showcases our capabilities and better reflects the dynamism of Fishawack as we collaborate with and integrate our new agencies,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “The new two-division structure provides clarity for our clients of the medical communications and creative offerings our expanding teams deliver across the globe.”


New Managing Director, Client Services, adds depth, leadership, and location to Carling

1st November 2018
Sherri Wilkins, President of Carling Communications, has announced the addition of veteran Lee Krauss as Managing Director, Client Services, paving the way for a US East Coast presence for the Creative arm of the Fishawack Group of Companies. Lee is tasked with leading the client services team as Carling takes on the growth challenges of new ‘agency of record’ clients. He will work closely with Sherri and the senior leadership team to expand the agency’s world-class offerings.

“We are excited to welcome Lee to Carling. He is a dynamic leader with a passion for delivering effective multichannel marketing strategies through online media partners, CRM, social platforms, broadcast, digital TV, and video,” said Sherri. “Lee has the talent and experience to grow our San Diego headquarters, our London office, and build an East Coast presence.”

Lee comes to Carling from Digitas Health in Philadelphia, US, where he has spent the last 5 years developing account teams and working with big pharma clients Merck, Sanofi, Gilead Sciences, and Mylan Pharmaceuticals. He spent another 5 years moving up through client services at Saatchi & Saatchi. Lee started his career as a pharmaceutical sales representative and product manager. This comprehensive background helps Lee focus on what’s important to clients and their brands – impacting and engaging the market effectively.

Fishawack Group acquires Healthcircle to strengthen creative offering

10th July 2018
The Fishawack Group of Companies, one of the world's largest independent medical communications and medical marketing organisations, has acquired Healthcircle Advertising Limited, a strategic brand communications agency with offices in London, UK, and Portugal.

"This acquisition is a major step in Fishawack's plan to build a global strategic creative agency that can work alongside our medical communications business," explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. "We also acquired US-based Carling Communications in July last year. Carling needed critical mass in Europe and Healthcircle needed a US partner. This is a great match and positions us to deliver integrated creative and medical communications solutions on a truly global scale."

Mike Taylor, Managing Director of Healthcircle, added: "We've been on the lookout for a partner to support our growth in the US whilst also providing us access to scientific and strategic talent. Healthcircle and Fishawack have already collaborated extensively and we've known and worked with many of the Carling team over our years in the business."

Gail Flockhart, Group Managing Director at Fishawack, said: All agencies are collections of people with different talents. What makes us different is the investment we make in establishing real chemistry between teams so that collaboration is fun and triggers new ideas. We're still at a size where we can make this meaningful.

Photo: Top row, Dominic Miller (Fishawack COO), Gail Flockhart (Fishawack Managing Director), Liz Maclaren (Healthcircle Creative Director), Dr David Ingram (Healthcircle Managing Partner); Bottom row, Mike Taylor (Healthcircle Managing Director), Oliver Dennis (Fishawack CEO).

Fishawack boosts healthcare marketing capabilities as Carling Communications joins the Group

6th July 2017
The Fishawack Group of Companies, one of the largest independent medical communications organisations, has acquired the Carling Group of Companies, based in San Diego, CA, USA, and including Carling Communications and MCME Global. Carling Communications is the first agency in the Fishawack Group to be focussed entirely on healthcare marketing, while MCME Global specialises in medical education.

Carling Communications was founded in 2010 by Didi Discar, leveraging over two decades of experience on the client and agency sides of pharmaceutical marketing. Carling has a team of nearly 100 who specialise in award-winning, full-service marketing, advertising, and physician communications for clients from the pharmaceutical, biotechnology, and medical device industries. Since its early focus in ophthalmology and dermatology, the agency has expanded its expertise to 35 therapeutic areas, including aesthetics, cardiovascular, diabetes, multiple sclerosis, and pain management.

“Fishawack has already made six strategic acquisitions to expand our reach, capabilities, and client base,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “Our new investor, LDC, is supporting us to expand the group further. Our clients comprise a mix of medical affairs and commercial teams, and we have always offered a complete range of services to the former and with the addition of a creative agency we can now do the same for the latter. I’ve known Didi and her team for over 7 years, frequently partnering with Carling for their promotional capabilities, so Carling is a natural fit as our creative agency.”

As part of a true global network, Didi Discar, Principal at Carling, believes that the company can achieve even more for its valued clients and employees. “I believe that this signals a new beginning in what we can bring to our clients. Our skills complement each other and provide synergies that will significantly benefit current and future clients, while building on our shared vision of excellence, integrity, and respect.”

“Fishawack will benefit from a significant increase in our team based out of the expanded West Coast presence,” commented Gail Flockhart, Group Managing Director at Fishawack. “Adding an office in San Diego to our one in San Francisco will allow us to deliver better service for our California-based clients.”

This deal marks the first acquisition Fishawack has made since mid-market private equity investor LDC backed the buyout of the business in January 2017. Simon Braham, Investment Director at LDC, said: “Over the past six months we have been working closely with Oliver and his team to implement their growth strategy. This is a major milestone for Fishawack and we look forward to continuing to support the team.”

The newly formed group of companies received guidance from Ruth Percival at BDO, Craig Scott and Michael Murphy of Hill Dickinson LLP (UK), Beni Surpin and Carrie Long of Foley & Lardner, and Ed Batts, Chris Trester, and Eric Wall from Orrick, Herrington & Sutcliffe LLP (USA). Mathias Reiter and Chris Wilson of KPMG provided tax advice.

Jenifer Kirkland joins the Fishawack Board as Chief Financial Officer

12th June 2017
The Fishawack Group of Companies is pleased to announce the appointment of Jenifer Kirkland as the Group’s Chief Financial Officer. Jenifer also joins the Fishawack Board, taking over the Chief Financial Officer role from Dominic Miller, who will assume the responsibilities of Chief Operations Officer, working closely with Oliver Dennis, Chief Executive Officer, on further agency acquisitions.

Jenifer originally qualified as a pharmacist before directing her career towards Finance. She has previously held positions at Ernst and Young, BT, Pearson, and Edif Group, and most recently was the Chief Financial Officer for Kinapse Ltd, the life sciences consultancy. Her familiarity with pharmaceutical clients as well as experience working with private equity will enable Jenifer to make an immediate contribution to the business in her new role.

“These are exciting times for the Fishawack Group as we continue to build both our global team and the breadth of services we offer our clients,” explained Oliver Dennis. “Jenifer’s experience and leadership will be invaluable to scaling up our finance function as we set out on our next phase of growth.”

“Jenifer will assume overall responsibility for Fishawack’s internal and external financial reporting,” said Dominic Miller, current Chief Financial Officer. “We’ve recently taken on investment from LDC, and having Jenifer on board will free up my time to pursue further acquisitions for the Group in the US and Europe.”

“Jenifer clicked with the current Board members as soon as we met,” added Gail Flockhart, Group Managing Director.

Jenifer Kirkland commented: “Having understood the Fishawack team’s strategy and plan to grow the Group, I am looking forward to being part of such a thriving company, contributing to the success, and meeting the teams across the offices who are making this happen.”